Changes in Blood Circulating Cell Populations May Reflect the Anti-Angiogenic and Chemosensitizing Effects of Bortezomib and Thalidomide Treatment in Patients with Multiple Myeloma.

Isabelle Vande Broek, Xavier Leleu, Dan Duda, Benjamin Van Camp, Karin Vanderkerken, Ivan Van Riet

    Research output: Contribution to journal › Meeting abstract (Journal)

    Fingerprint

    Dive into the research topics of 'Changes in Blood Circulating Cell Populations May Reflect the Anti-Angiogenic and Chemosensitizing Effects of Bortezomib and Thalidomide Treatment in Patients with Multiple Myeloma.'. Together they form a unique fingerprint.

    Medicine & Life Sciences

    Chemistry